Northstar Neuroscience, Inc. Announces Preliminary Findings From Study Of Cortical Stimulation To Treat Stroke-Related Broca’s Aphasia Will Be Presented At Prestigious Rehabilitative Medicine Meeting

SEATTLE--(BUSINESS WIRE)--Sept. 21, 2006--Northstar Neuroscience, Inc. (NASDAQ: NSTR), a developer of medical devices for the treatment of neurological diseases and disorders, today announced that preliminary data from its 8 patient feasibility study of cortical stimulation to treat stroke-related Broca's aphasia will be presented at the American Congress of Rehabilitative Medicine / American Society of Neurorehabilitation Joint Educational Conference, which will be held in Boston on September 27-30, 2006.
MORE ON THIS TOPIC